Regeneron Pharmaceuticals
REGN
#284
Rank
A$107.09 B
Marketcap
$979.61
Share price
-2.72%
Change (1 day)
-34.43%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): $56.24

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $59.32. In 2022 the company made an earnings per share (EPS) of $64.33 a decrease over its 2021 EPS that were of $121.38.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$56.24-12.58%
2022$64.33-47%
2021$121.38133.36%
2020$52.0169.13%
2019$30.75-14.44%
2018$35.95100.71%
2017$17.9131.78%
2016$13.5938.96%
2015$9.7872.55%
2014$5.67-17.55%
2013$6.87-44.98%
2012$12.50-422.54%
2011-$3.8792.13%
2010-$2.0249.41%
2009-$1.35-15.84%
2008-$1.60-36.88%
2007-$2.54-9.6%
2006-$2.814.12%
2005-$2.70-323.68%
2004$1.21-135.51%
2003-$3.40-24.38%
2002-$4.4956.35%
2001-$2.87187.3%
2000-$1.00-16%
1999-$1.19177.78%
1998-$0.43-35.71%
1997-$0.67-68.42%
1996-$2.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$22.47-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.53-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$29.31-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.36-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.94-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$5.05-91.49%๐Ÿ‡ซ๐Ÿ‡ท France